Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients

J Neurol. 2013 Jan;260(1):327-9. doi: 10.1007/s00415-012-6744-7. Epub 2012 Nov 16.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Disability Evaluation
  • Female
  • Fingolimod Hydrochloride
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Magnetic Resonance Imaging
  • Middle Aged
  • Multiple Sclerosis / drug therapy*
  • Propylene Glycols / administration & dosage*
  • Recurrence
  • Sphingosine / administration & dosage
  • Sphingosine / analogs & derivatives*
  • Substance Withdrawal Syndrome / drug therapy
  • Substance Withdrawal Syndrome / etiology*

Substances

  • Immunosuppressive Agents
  • Propylene Glycols
  • Fingolimod Hydrochloride
  • Sphingosine